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Recall of medical information is notoriously poor. In meth-odologically rigorous studies of cancer patients’ recall,our group found that patients recall about 25% of all the
facts presented and just under half of the five to six facts
nominated as particularly crucial by the doctor.1 Studies on
genetic counselling, on the other hand, generally show that
genetic counselling appears to be effective in increasing
knowledge of the mode of inheritance.2 However, risk figures
are generally poorly recalled, suggesting that there may be
potential for improving the effectiveness of information
giving.3
Several sources of poor patient understanding have been
identified, including poor communication techniques and lack
of time in the consultation,4 patient anxiety,4 5 and patient
denial.6 Thus, interventions designed to improve patient
understanding need to compensate for anxiety and time con-
straints by providing a mechanism for flexible information
review, to be sensitive to patients’ varying information needs,
and to be economical in time and costs. An audiotape of the
consultation appears to satisfy these criteria.
A recent review of published reports on audiotaping in the
oncology consultation concluded that providing audiotapes to
patients is beneficial.7 It can allow for review of the
information presented, serve as a stimulus for future
discussion, facilitate family communication about the illness,
and can be a clinically effective intervention as it is
inexpensive and easily incorporated into clinical practice.
Studies have examined the effect of audiotapes on patients’
psychological well being, information recall, and satisfaction.
Results for psychological well being have been conflicting.
Studies have ranged from showing a significant reduction in
anxiety,8 to no reduction,1 to showing a detrimental effect.9
Differences in findings may be partly explained by the hetero-
geneity of samples studied. For example, studies included
patients with advanced carcinomas,8 both newly and previ-
ously diagnosed patients,9 and patients with both local and
metastatic disease.1
Studies examining the effect of providing patients with
audiotapes on information recall have also produced mixed
results. Tattersall et al10 compared the effects of an audiotape of
the consultation with an individualised summary letter.While
patients preferred audiotapes to letters, patient recall was not
differentially affected.10 A randomised controlled trial con-
ducted by Dunn et al,1 comparing a consultation audiotape, to
a general cancer information tape, or no tape, showed no dif-
ference in recall between patients receiving the consultation
tape and those receiving no tape, although patients in the
general tape group recalled significantly less.1 However, several
studies8 9 found the tape group able to recall significantly more
information.
In their review,McClement et al7 concluded that satisfaction
bias among patients, the validity of instruments measuring
satisfaction, and the social and cultural context that impacts
on patients’ expectations of their physicians combine to
confound studies on the effectiveness of audiotapes on patient
satisfaction.
Only one study to date has assessed the efficacy of
audiotape provision in women attending a familial cancer
clinic.11 Watson et al11 randomly assigned 115 women with a
family history of breast cancer to receive or not to receive an
audiotape of their genetic counselling consultation. The
results showed that provision of the audiotape significantly
reduced cancer worries but did not influence the accuracy of
perceived risk.11
As taping can only reflect the style of counselling initially
provided, and as this is likely to vary across cultures and
between individual counsellors, it is important to replicate this
study in another country with a different population. In addi-
tion, Watson et al11 included only unaffected women in their
Key points
• In this randomised controlled trial in women from high
risk breast cancer families, a strategy to assist women to
understand and cope better with their situation was
assessed. A total of 109 unaffected and 84 affected
women who attended any one of 10 familial cancer
clinics were randomly assigned to receive or not to
receive an audiotape of their initial genetic counselling
consultation. They completed self-report questionnaires
two weeks before and three weeks after that initial con-
sultation.
• Fifty one percent of the women randomised to receive
the tape listened to it at least once. Unaffected women
randomised to receive an audiotape were significantly
less likely to be accurate in their risk perception at follow
up (p=0.05) than unaffected women randomised not to
receive the audiotape. However, a risk figure or
category was given in only 52% of the audiotaped con-
sultations with unaffected women. Only 39% of affected
women were given a risk figure of the chances of getting
a second breast cancer.
• The tape had no effect on risk accuracy when the analy-
sis included only women who were inaccurate at base-
line. There was a trend for women who received an
audiotape to have improved scores on depression at
follow up (p=0.06), but no association was found with
other patient outcomes. When the analysis was
repeated including in the intervention arm only women
who had listened to the tape, those receiving the inter-
vention had a significantly larger reduction in anxiety
(p=0.02) and a greater reduction in depression
(p=0.01).
• The provision of an audiotape and listening to it after the
genetic counselling session had a beneficial effect in
reducing women’s anxiety and depression but did not
improve their ability to process information concerning
their breast cancer risk.
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sample, while a large proportion of those attending family
cancer clinics have previously been diagnosed with cancer.
Furthermore, no previous audiotaping study has explored
whether coping style influences how beneficial a tape is
perceived. The current study aimed to assess the provision of
an audiotape of the genetic counselling consultation in a large
sample of both unaffected and affected women attending a
familial cancer clinic using validated measures of psychologi-
cal outcome.We hypothesised that women in the intervention
group would (1) be more accurate in their risk perception, (2)
be more satisfied overall and more satisfied with the
information they received, (3) be less anxious and depressed
and have less intrusive or avoidant thoughts about breast can-
cer, (4) have higher knowledge, and (5) have more of their
expectations met. In addition, (6) it was hypothesised that
women who were “monitors” and received a copy of the
audiotape would be more satisfied, have increased knowledge,




Consecutive women attending any one of 10 familial cancer
clinics in four Australian states (New South Wales, Victoria,
South Australia, and Queensland) were invited to participate
in the study. Quota sampling was used to ensure that the
sample consisted of equal numbers of affected and unaffected
women. Women were considered ineligible for participation if
they were unable to give informed consent, that is, if they were
younger than 18 years or showed evidence of a severe mental
illness. Women with limited literacy in English were also
excluded because data collection was based on self-
administered questionnaire.
Sample size
A sample size of 160 for the randomised trial was considered
sufficient to detect groupmean differences of 0.4 of a standard
deviation (that is small to medium effect size) on the psycho-
logical and patient satisfaction measures with a power of 80%.
When comparing proportions, it would be possible to detect
differences of approximately 20% or more between interven-
tion and control groups at 0.05 level of significance with 80%
power.
Procedure
Staff at each of the participating familial cancer clinics invited
women to participate in the study when they telephoned to
make their appointment. Women were subsequently tele-
phoned by the central research staff and given further
information about the study. Questionnaires, consent forms,
and reply paid envelopes were mailed to consenting women by
the coordinating research centre approximately two weeks
before their clinic appointment. Women were asked to return
the completed baseline questionnaire and the consent form
before attending the familial cancer clinic. A follow up
questionnaire was mailed three weeks after counselling.
The consultations were audiotaped and women were
randomised immediately after their consultations to receive or
not to receive the audiotape. Randomisation allocation was
predetermined by the coordination centre using sealed
envelopes to ensure the familial cancer clinic staff would be
blind to the randomisation. Randomisation was done within
clinics to help balance potential provider variability across
intervention and control groups. Ethical approval from 10 dif-
ferent ethics committees responsible for each of the participat-
ing clinics was sought and obtained before data collection.
Measures
Demographic characteristics
Age, educational level, occupation, marital status, medical or
allied health training, number of biological children, and
number of first and second degree relatives who had
developed breast or ovarian cancer were assessed at baseline.
Expectations
Women were asked to (1) indicate on a five point scale rang-
ing from “not at all important” to “very important” their
response to seven possible reasons for attending a genetic
clinic and (2) similarly rate nine possible information topics
that they might want covered at their first appointment. This
scale was developed specifically for this study and included
items suggested by expert opinion, previous publications, and
structured telephone interviews with at risk women. After the
consultation, women were asked to rate on a five point scale
ranging from “not at all” to “a lot” the degree to which they
perceived they had been informed about particular infor-
mation items and whether other expectations were met in a
“Yes/No” format. A total score for the number of expectations
met was calculated by summing those items for which a “yes”
was given and those indicating that at least some information
had been given.
Breast Cancer Knowledge Scale
This eight item true-false measure assesses knowledge about
breast cancer genetics, yielding a total score of 0-8. The scale is
a revised version of a scale originally developed by Lerman et
al12 and has previously been found to have moderate internal
consistency with Cronbach’s alpha of 0.59.
Psychological measures
Impact of Events Scale
This 15 item validated scale measures intrusion and avoidance
responses in relation to a specific stressor.13 In the current
study, the particular stressor was concern about being at risk
of developing breast cancer for unaffected women and
concern about developing a second cancer for affected women.
In a previous validation study of women with a family history
of breast cancer, the intrusion and the avoidance subscales
have been found to be highly consistent with Cronbach’s coef-
ficient alphas of 0.84 and 0.91, respectively, and a test-retest
reliability of r=0.80.14
Hospital Anxiety and Depression Scale
This 14 item scale has been found to be valid and reliable in
detecting depression and anxiety in hospital medical out-
patient clinics. It consists of two subscales of seven items
assessing the level of anxiety and depression.15 Scores range
from 0 to 42. Questions have four response options, yielding
scores ranging from 0-21 for each subscale. A score of higher
than 10 on either subscale is an indication of clinical anxiety
or depression, and scores from 8-10 on either subscale are
indicative of “borderline” anxiety and depression.
Monitoring-Blunting Style Scale
This eight item, validated scale measures individual differ-
ences in coping styles in threatening situations. The scale asks
participants to imagine four stress provoking scenarios of a
largely uncontrollable nature. Each scenario is followed by
eight statements representing different attention strategies
for dealing with the event, that is “monitoring” (sensitising,
vigilance) versus “blunting” (avoidance). A final score is
obtained by subtracting the total blunters score from the total
monitors score as blunting is seen to be the opposite of moni-
toring.
Risk perception
Women were asked to indicate their perceived approximate
lifetime risk of breast cancer (that is, to age 80) by choosing
between seven response options ranging from 1% to 100%. A
decision was made to code women’s risk accuracy within cat-
egories, as risk estimates vary widely and often only a risk
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category (for example, high, medium, or low) is given in the
genetic counselling session. Participants’ numerical estimate
of life time risk was converted to a category according to the
figures given in the Australian National Health and Medical
Research Council Guidelines, for example, a potentially high
risk category 25% to 80%, a medium risk category 12% to 25%,
and a low risk category 9% to 12%.16
Objective risk was determined by the figure given by the
clinical geneticist/genetic counsellor in the consultation or the
post-consultation summary letter. Participants’ responses
were deemed accurate if their risk estimate fitted within the
risk category given by the clinical geneticist or genetic
counsellor. If women were inaccurate it was determined
whether they had underestimated or overestimated their risk
of breast cancer.
Satisfaction with the genetic counselling session
Satisfaction was measured using a modified version of the 12
item short form of the 36 item “Satisfaction with Genetic
Counselling Scale”, developed by Shiloh et al.17 This shorter
version of the scale is highly correlated with the full scale
(r=0.90) and has good reliability (Cronbach α=0.78). Items
cover the following five aspects of satisfaction: (1) satisfaction
with affective elements of the consultation, for example, did
he/she listen to you, show enough dedication, and understand
what was bothering you; (2) satisfaction with the instrumen-
tal elements, for example, did the geneticist explain your situ-
ation clearly, did he/she reassure you, and can the counselling
you received help you cope better; (3) satisfaction with the
procedural elements, for example, did the waiting time for an
appointment bother you; (4) satisfaction with the information
content; and (5) women’s overall satisfaction. Women also
responded to a series of open ended questions about what they
liked about the consultation.
Satisfaction with audiotape
Women randomised to receive the audiotape answered seven
additional questions specifically addressing satisfaction with
the tape. These questions were based on a previous study and
had been validated in a cancer population.1 Women were
asked how often they listened to the audiotape, if they gave
the tape to anyone else to listen to, and, if so, to whom. They
were then asked to indicate on a five point Likert Scale how
useful the tape was in (1) increasing their understanding of
cancer genetics; (2) increasing their understanding of their
personal risk; (3) decreasing their anxiety about breast cancer;
(4) assisting in family communication about the family
history of breast cancer; (5) helping the family understand
breast cancer genetics; (6) helping to reach a decision about
how to manage their genetic risk; and (7) helping to reach a
decision about having a genetic test. Finally, women were
asked in an open ended question to list other ways in which
the audiotape was helpful or unhelpful.
Timing of assessment
All measures were included at baseline and follow up, except
demographics, expectations, and coping style (measured only
at baseline) and satisfaction (measured only at follow up).
Statistical analyses
Descriptive statistics were used to describe the sample in
terms of sociodemographic, family history, and psychological
variables. Exploration of possible bias in the randomised
groups, and in those who were and were not lost to follow up,
was undertaken by comparing demographic, family history,
and psychological characteristics across groups using Mann-
Whitney U tests, t tests, and chi-squares as appropriate.
Change scores were calculated for psychological measures and
knowledge by subtracting follow up from baseline scores and
these were used in subsequent analyses. Univariate analyses
(Mann-Whitney U tests, t tests, and chi-squares as appropri-
ate) were used on an “intention to treat” basis to compare the
groups on outcomes such as accuracy of risk perception, satis-
faction, and change in knowledge and psychological out-
comes. Intention to treat analyses, the gold standard in
randomised trials, minimise bias introduced by differential
loss to follow up between groups and different reasons for
dropping out between groups. The possibility of an interaction
between coping style and tape allocation was explored by lin-
ear and logistic regression including an interaction term.
RESULTS
Participants
Of the 244 women who met eligibility criteria, 195 women
were randomised to evaluate the impact of an audiotape. One
hundred and sixty women completed both the baseline and
follow up questionnaire (82% retention rate, fig 1). Eighty-two
of these women received the tape and 78 did not. Table 1
shows the comparison of sociodemographic, family history,
and psychological variables between intervention and control
groups at baseline.
There were no important differences (and no statistically
significant differences between the groups) indicating that the
randomisation had successfully equalised potential confound-
ers between the groups.
Analysis of participation bias
We next compared those women who completed both the
baseline and follow up questionnaires (n=160) and those lost
to follow up (n=20). The groups were similar in all respects.
Similar numbers of women were lost to follow up in the inter-
vention (n=13) and control (n=16) groups.
Use of the audiotape
Of the 98 women randomised to receive the audiotape of their
consultation, 49% did not listen to it. Thirty-one percent
reported that they listened to it once. Sixteen percent reported
listening to it twice, 3% three times, and one woman reported
that she had listened to it more than three times. Twenty
women (20%) reported that they shared the audiotape of the
consultation with another family member. Listening to the
audiotape was not associated with coping style (monitoring or
blunting). Women who chose not to listen to the tape prima-
rily reported they had no use for the tape at present but fore-
saw that it would be of great benefit in the future either to
themselves or to younger generations. Only one woman
reported that she did not want to relive “the agony and emo-
tional heartache” of the consultation.
Univariate analyses showed that affected women (χ21=4.65,
p=0.03) and women with increased generalised anxiety at
baseline (Z=−2.51, p=0.01) were significantly more likely to
listen to the audiotape. There was a trend for women who
were more depressed (Z=−1.889, p=0.06) and had lower
breast cancer genetics knowledge (Z=−1.819, p=0.07) to
listen to the audiotape.
The impact of receiving the audiotape on women’s risk
perception
Table 2 shows the differences on outcome variables for the
intervention and control groups. We hypothesised that the
intervention group would have increased accuracy. We were
only able to analyse data for unaffected women as affected
women were not routinely given a risk figure in either their
consultation (39%) or post clinic letter (25%) for the chances
of a second breast cancer occurring. Risk assessment figures or
categories were not given to all unaffected women at the time
of the consultation either. However, most clinic letters did
contain a risk estimate, and were mailed out before
completion of the follow up questionnaires; only five
unaffected women who received a tape did not receive a risk
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estimate in either the consultation or the letter. Nevertheless,
the results of this analysis must be viewed with caution as the
final number of unaffected women who received a risk
estimate and an audiotape for which outcome data were
available (n=42) may have been insufficient to detect a small
effect size.
Contrary to the hypothesis, unaffected women who were
randomised to receive an audiotape after their consultation
(n=48) were significantly less likely to be accurate in their
risk perception at follow up (χ21=3.89, p=0.05), compared to
those who did not receive an audiotape (n=44). Fifty-six per-
cent of unaffected womenwho received the tape were accurate
at follow up compared to 76% who did not receive the tape.
However, when only those women who were inaccurate at
baseline were included in the analysis (n=40), the tape had no
effect on the accuracy of their risk perception at follow up
(χ21=1.57, p=0.21).
As only 52% of consultations with unaffected women
included a risk figure or category, while almost all follow up
letters included an estimate of risk, we analysed the impact of
reading the follow up letter on risk perception. Univariate
analysis showed a trend towards significance for those women
who received a summary letter of their consultation, and said
they read it, to have more accurate risk perception at follow up
(56% versus 37%) (χ21=3.166, p=0.07).
Impact of receipt of audiotape on other outcome
variables
Compared to women in the control group, women who were
randomised to receive a copy of the audiotape after the
consultation were no more satisfied with the consultation as a
whole (Z=−0.82, p=0.41), nor with the information they
received (t152=0.353, p=0.72). They also did not have a greater
sense of their expectations being met (t138=0.272, p=0.78).
Figure 1 Overview of recruitment.
Table 1 Comparison of sociodemographic, family
history, and psychological variables between
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Total relatives diagnosed or died Median 2 Median 2
Psychological measures
Baseline anxiety score Median 6.0 Median 7.0
Baseline depression score Median 4.0 Median 5.0
Baseline intrusion Median 12.0 Median 11.0
Baseline avoidance Median 14.0 Median 14.0
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Similarly, receiving an audiotape did not increase women’s
knowledge of breast cancer genetics (t152=1.257, p=0.21).
The majority of unaffected and affected women had normal
scores on the Impact of Events Scale (intrusion and avoidance
responses) before counselling. A small subgroup of unaffected
(10%) and affected (19%) women showed significant stress
responses. Almost one fifth of unaffected and affected women
attending for genetic counselling were clinically anxious and
18% of unaffected women and 28% of affected women were
“borderline” clinically anxious. Five percent (5%) of both
unaffected and affected women were clinically depressed and
8% of unaffected and 16% of affected women were “border-
line” clinically depressed. These results are not dissimilar to
others reported for affected and unaffected women.18 19
Compared to the normal population, levels of psychological
morbidity were not notably high for unaffected women, but
anxiety was certainly higher in affected women and if
probable cases are included, rates of clinically significant
depression were also higher.
Change in general anxiety (t130=0.812, p=0.420) and
changed scores on the Impact of Events Scale (avoidance
(t120=−0.680, p=0.49) and intrusion (t120=−0.152, p=0.88)
were not affected by audiotape randomisation. However, there
was a trend for women who received the audiotape to have
significantly improved depression scores at follow up
(t130=1.866, p=0.06).
These analyses were repeated, including in the intervention
group only those who reported actually listening to the tape
(n=45) and the whole control group (n=79). It is acknowl-
edged that this may have introduced bias, but it was felt to be
useful in further investigating the impact of the tape. The
results were similar, except that significant results were
obtained for general anxiety and depression. That is, women
randomised to receive the tape who listened to it, had a
significantly larger reduction in anxiety (mean change score of
−1.6944) compared to those who were randomised not to
receive the tape (mean change score of −0.2923) (t99=2.255,
p=0.02). Continuing the trend, women randomised to receive
the audiotape, who listened to it, had a significantly greater
reduction in depression (mean change score of −2.6389) com-
pared to those who were randomised not to receive the audio-
tape (mean change score of −1.2000) (t99=2.592, p=0.01).
Other outcomes were not significantly different between the
groups including risk perception.
To test the hypothesis that the tape would have a differen-
tial effect onmonitors and blunters we included an interaction
term in regression analyses. On all outcomes the interaction
term was not significant. Thus, the tape appeared to have had
the same effect regardless of the woman’s score on the
monitoring/blunting measure.We wondered if larger numbers
of monitors listened to the tape; however a cross tab analysis
did not support this with 63% of monitors listening to the tape
compared to 51% of blunters (χ21=1.026, p=0.31).
Satisfaction with audiotape
Of the women randomised to receive the tape and who
listened to it, the majority found the audiotape helpful. The
areas that the tape was perceived as either satisfactory, very or
extremely helpful were in increasing women’s understanding
of breast cancer genetics (94%); assisting in family communi-
cation (92%); helping the family understand about breast
cancer genetics (89%); decreasing women’s anxiety about
breast cancer (77%); helping women make a decision about
having genetic testing (85%); and making a decision about
managing their genetic risk (84%). Only 20% of women found
the tape satisfactory, and 35% found it very or extremely help-
ful in terms of increasing their understanding of their
personal risk.
Women were asked to list other ways in which they found
the audiotape helpful. Only eighteen women provided
additional responses. The main area identified was to “jog
your memory” and to have the tape for future reference, for
example, “ability to recall complex issues discussed”. To be
able to share the tape with relatives was also noted, for exam-
ple, “tape is great idea for future for younger children who are
too young now”. One woman said the tape was “a reminder
that there is someone to turn to”, but one women was not
happy with the audiotape because “(I) didn’t want to relive
agony/emotional heartache”.
DISCUSSION
One hundred and ninety-five women with a family history of
breast cancer, both affected and unaffected, were randomly
assigned to receive or not receive an audiotape of their genetic
consultation. The results show that of the 98 women who
received the audiotape, half of them listened to it, which is
similar to the findings of Watson et al11 in their study of audio-
tape provision in genetic counselling. This suggests that such
interventions may be attractive to some but not to others. In
particular, in this study, women who had had breast cancer,
and those who were more anxious and depressed and had less
knowledge of breast cancer genetics were more likely to listen
to the audiotape. Thus, it appeared to be particularly helpful to
vulnerable subjects and this might guide the clinician who
had scarce resources in determining which women might
benefit most from this intervention. The majority of partici-
pants reported high satisfaction with the tape and listed a
number of ways they found it useful, such as to prompt recall,
assist family communication (including future generations),
and reinforce reassuring messages.
In oncology consultations, while most studies of audiotape
provision in initial consultations have reported almost univer-
sal use, in a recent study by our group of audiotape provision
in the setting of routine follow up, only 68% elected to take the
tape home when offered the choice.20 Refusers most com-
monly felt the tape would serve no useful purpose. Thus, in
less intense clinical encounters, where patients are perhaps
less overwhelmed by emotion, audiotapes may be valued by
fewer patients. Interestingly, in the above oncology follow up
study, almost all of those who elected to take the tape home
also listened to it, suggesting that offering choice is an effec-
tive way to ensure that only those who will benefit receive the
tape.11 Similarly, Hack et al21 found that patients who chose to
receive an audiotape of their primary adjuvant treatment con-
sultation exhibited significantly greater information recall
than those who received the tape without choice or those who
did not have the tape.21
Written summaries of genetic counselling sessions have
been found to be useful as a “memory aide”, but also in
assisting in the dissemination of information among family
members.22 Similarly, audiotapes of consultations could be
useful. However, while few women listened to their audiotape,
even fewer shared it with family members. Perhaps there was
material on the tape of a sensitive nature. It has been
Table 2 Mean change scores for outcome variables








Overall satisfaction (median) 90 90
Satisfaction with information (mean) 0.8333 0.8537
Expectations met (mean)* 4.0154 4.0933
Change in knowledge (mean) 1.2568 1.5625
Change in anxiety (mean) −0.7656 −0.3382
Change in depression (mean) −2.1094 −1.2794
Change in intrusion (mean) −0.9643 −1.0909
Change in avoidance (mean) −1.2857 −1.8182
*Possible range in expectations met 0–12.
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suggested that when people are given the option of receiving
an audiotape, they are also given the option of turning the
tape off during particular sections of the consultation if they
are concerned about sharing this information with other fam-
ily members.11
Only just over half the women who received and listened to
the tape perceived it as helpful in increasing their understand-
ing of personal risk. This perception was supported by our
findings, as contrary to our hypothesis that unaffected women
randomised to receive an audiotape would be more accurate,
they were actually less likely to be accurate in their risk
perception at follow up. Fifty-six percent of unaffected women
who received the tape were accurate at follow up compared to
76% who did not receive it. However, the audiotape had no
effect on accuracy when the analysis was restricted to women
who were inaccurate at baseline. Perhaps the finding in the
whole sample is a statistical aberration; it is certainly hard to
explain otherwise. Alternatively, restricting the sample to
those inaccurate at baseline (n=40) may have resulted in
insufficient power. Watson et al11 also found that audiotape
provision did not increase risk accuracy in a genetic counsel-
ling population.
It should be noted that a risk figure was given in only 52%
of the audiotaped consultations with unaffected women.
While most unaffected women did receive a figure in their fol-
low up letter and thus we were able to calculate their objective
risk, provision of the audiotape would not have helped those
women whose consultations had not provided a specific risk
category or figure. This interpretation is supported by the fact
that in women who received a post consultation summary let-
ter there was a strong trend towards improved accuracy of
recall. This finding raises an issue often neglected in studies of
audiotape provision, that is, that replication of communication
will only ever be as useful as the original discussion. However,
this consideration does not affect the results of our study other
than to restrict power, because the proportion of women
receiving risk estimates is the same in each group owing to the
randomised design.
It was only possible to analyse data for unaffected women
as affected women were not routinely given a risk figure (in
either their consultation or follow up letter) for the chances of
a second breast cancer occurring. Therefore, whether they
were inaccurate or accurate in their risk perception, or if the
audiotape affected their risk accuracy, could not be assessed.
While Watson et al11 found an audiotape of the genetic
counselling session did not impact on risk accuracy, they did
find that the audiotape significantly reduced cancer worries.
The current study found a trend for women who received the
tape to have significantly improved scores on depression at
follow up but not reduced intrusive worries about cancer.
When the analysis was repeated, including in the intervention
arm only those women who listened to the tape, the results
showed significant reduction in anxiety and a significant
reduction in depression. Thus, the tape did appear to have a
positive impact on psychological outcomes in those who chose
to listen to the tape, although this result could reflect bias in
excluding those who did not listen to the tape and may have
been more psychologically distressed. Watson et al11 suggested
that some women require regular reassurance and may use
the tape for this purpose. Perhaps hearing this discussion
again on the audiotape with the reinforcement of the
supportive and counselling behaviours of the consultants has
a positive effect on women’s anxiety.
This study found that coping style (monitoring versus
blunting) did not influence the likelihood that women would
listen to the tape, nor their responses to the tape. These were
surprising findings, as previous studies have reported a greater
preference for and benefit from additional information in
women with a monitoring coping style. Women who attended
for genetic counselling in this study tended to be of higher
education and professional status than the general popula-
tion, and there were more monitors than there were blunters.
Therefore, there may have been insufficient variability on this
measure to allow differences to be observed. Another
possibility is that the material on the tape was not sufficiently
threatening to provoke a “coping response” in these women.
In conclusion, our findings suggest that the provision of an
audiotape after the genetic counselling session may have a
beneficial effect in reducing anxiety and depression, although
further studies are required to confirm this finding. In our
sample, provision of the tape appeared to have a detrimental
effect on women’s ability to process information concerning
their breast cancer risk. While hearing the same words twice
may not improve recall without additional opportunities to
clarify misconceptions, there is no apparent reason why it
should worsen the situation. A more likely explanation is that
these results were a chance finding and stronger conclusions
require replication. As a cost effective, non-time consuming
intervention, audiotaping merits consideration for routine
inclusion into clinical practise, perhaps supplemented by
other strategies (for example, summary letters, tailored infor-
mation) to target risk perception. It is suggested that women
be given a choice about receiving the audiotape to ensure that
only those who will benefit will receive it and also to address
the issue of the disclosure of confidential information as
highlighted by previous authors.11
In addition, audiotaping has other uses apart from provid-
ing patients with a record of their consultation. For example,
it can allow auditing of clinical practice, provide an objective
benchmark for patient recall, and provide the basis for
research into the influence of clinician knowledge or patient
outcomes.
ACKNOWLEDGEMENTS
The authors would like to thank the following people for their contri-
bution to this study: Meryl Smith, Margaret Gleeson, Monica Tucker,
Sue Shanley, Karen Harrop, Annette Hattam, Jillian Parkes, Anne
Baxendale, Linda Warwick, Mary-Anne Young, Clara Gaff, Lisette
Curnow, Graeme Suthers, Jacqueline Armstrong, Elizabeth Dent,
Lynda Gill, Mercedes Moreno, and Rhonda Devine for assistance with
patient recruitment, data collection, and audiotape coding. Finally, we
are grateful for the valuable contribution of all the women who
participated in this study. This study was funded by the University of
Sydney Cancer Research Fund. Bettina Meiser is supported by Public
Health Australia Fellowship 007079 from the National Health and
Medical Research Council of Australia
. . . . . . . . . . . . . . . . . . . . .
Authors’ affiliations
E Lobb, P Butow, Medical Psychology Research Unit, Department of
Psychological Medicine, University of Sydney, Sydney, NSW 2006,
Australia
P Butow, B Meiser, Department of Psychological Medicine, Royal North
Shore Hospital, St Leonards, NSW 2065, Australia
A Barratt, Department of Public Health and Community Medicine,
University of Sydney, Sydney, NSW 2006, Australia
J Kirk, Familial Cancer Service, Westmead Hospital, Westmead, NSW
2145, Australia
M Gattas, Queensland Clinical Genetics Service, Royal Children’s
Hospital, Herston, Queensland 4006, Australia
E Haan, South Australian Clinical Genetics Service, Women’s and
Children’s Hospital, Adelaide, 5000 South Australia
K Tucker, Hereditary Cancer Clinic, Prince of Wales Hospital,
Randwick, NSW 2031, Australia
Correspondence to: Dr E Lobb, Medical Psychology Research Unit,
Department of Psychological Medicine, University of Sydney, Sydney,
NSW 2006, Australia; lizlobb@med.usyd.edu.au
REFERENCES
1 Dunn S, Butow PH, Tattersall MHN, Jones QJ, Sheldon JS, Taylor JJ,
Sumich MD. General information tapes inhibit recall of the cancer
consultation. J Clin Oncol 1993;11:2279-85.
2 Clarke A, Parsons E, Williams A. Outcomes and process in genetic
counselling. Clin Genet 1996;50:462-9.
3 Evans DGR, Blair V, Greenhalgh R, Hopwood P, Howell A. The impact
of genetic counselling on risk perception in women with a family history
of breast cancer. Br J Cancer 1994;70:934-8.
702 Letter
www.jmedgenet.com
 on 11 September 2008 jmg.bmj.comDownloaded from 
4 Ley P. Communicating with patients: improving communication
satisfaction and compliance. London: Croom Helm, 1988.
5 Ley P, Spelman MS. Communications in an outpatient setting. Br J Soc
Clin Psychol 1965;4:144-16.
6 Cassileth BR, Zupkis RV, Sutton-Smith K, March V. Information and
participation preferences among cancer patients. Ann Intern Med
1980;92:832-6.
7 McClement SE, Hack TF. Audio-taping the oncology treatment
consultation: a literature review. Pat Educ Counsel 1999;36:229-38.
8 North N, Cornbleet MA, Knowles G, Leonard RCF. Information giving in
oncology: a preliminary study of tape-recorder use. Br J Clin Psychol
1992;31:357-9.
9 McHugh P, Lewis S, Ford S. The efficacy of audio-tapes in promoting
psychological well-being in cancer patients: a randomised controlled
trial. Br J Cancer 1993;71:388-92.
10 Tattersall MHN, Butow PN, Griffin A, Dunn SM. The take home
message: patients prefer consultation audiotapes to summary letters. J
Clin Oncol 1994;12:1305-11.
11 Watson M, Duvivier V, Wade Walsh M, Ashley S, Davidson J,
Papaikonomou M, Murday V, Sacks N, Eeles R. Family history of breast
cancer: what do women understand and recall about their genetic risk? J
Med Genet 1998;35:731-8.
12 Lerman C, Narod S, Schulman K, Hughes C, Gomez-Caminero A,
Bonney G, Gold K, Trock B, Main D, Lynch J, Fulmore C, Snyder C,
Lemon SJ, Conway T, Tonin P, Lenoir G, Lynch H. BRCA1 testing in
families with hereditary breast-ovarian cancer. JAMA 1996;275:1885-92.
13 Horowitz MJ, Wilner N, Alvarez W. Impact of Event Scale: a measure
of subjective stress. Psychosom Med 1979;41:209-18.
14 Thewes B, Meiser B, Hickie I. Validation of the Impact of Events Scale in
women at increased risk of developing hereditary breast cancer.
Psycho-Oncol 2001;10:459-68.
15 Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale.
Acta Psychiatr Scand 1983;67:361-70.
16 NH & MRC. Familial aspects of cancer: a guide to clinical practice.
Canberra: National Health and Medical Research Centre, 1999.
17 Shiloh S, Avdor O, Goodman RM. Satisfaction with genetic counselling:
dimensions and measurement. Am J Med Genet 1990;37:522-9.
18 Maguire P, Tait A, Brooke M. Effect of counselling on the psychiatric
morbidity associated with mastectomy. Br Med J 1980;281:1454-6.
19 Meiser B, Butow PN, Schnieden M, Gattas M, Gaff C, Harrop K,
Bankier A, Young M, Tucker K. Psychological adjustment of women at
increased risk of developing hereditary breast cancer. Psychol Health
Med 2000;5:377-88.
20 Knox R, Butow PN, Devine R, Tattersall M. Audio-tapes in oncology
consultations: only the first? Ann Oncol (in press).
21 Hack TF, Pickles T, Bulz B. Providing audio tapes of primary adjuvant
treatment consultations to cancer patients: a multicentre randomised trial.
Clin Oncol Soc of Aust Ann Scien Mtg, Adelaide, Australia, 2000.
22 Hallowell N, Murton F. The value of written summaries of genetic
consultations. Pt Educ Counsel 1998;35:27-34.
Correction
In the June issue of the journal (J Med Genet 2002;39:434–9)
in the paper by Weise et al, there was an error in one of the
authors’ name and affiliation. S Gabriele should have been
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